rs772002851
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 3P and 2B. PM1PP2BP4_Moderate
The NM_000152.5(GAA):c.794G>A(p.Ser265Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000236 in 1,612,974 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S265R) has been classified as Uncertain significance.
Frequency
Consequence
NM_000152.5 missense
Scores
Clinical Significance
Conservation
Publications
- glycogen storage disease IIInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, G2P
- glycogen storage disease due to acid maltase deficiency, infantile onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- glycogen storage disease due to acid maltase deficiency, late-onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152206Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 250936 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000240 AC: 35AN: 1460768Hom.: 0 Cov.: 33 AF XY: 0.0000275 AC XY: 20AN XY: 726712 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152206Hom.: 0 Cov.: 34 AF XY: 0.0000403 AC XY: 3AN XY: 74354 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Glycogen storage disease, type II Pathogenic:1Uncertain:4
- -
This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 265 of the GAA protein (p.Ser265Asn). This variant is present in population databases (rs772002851, gnomAD 0.02%). This missense change has been observed in individual(s) with Pompe disease (PMID: 34864681). ClinVar contains an entry for this variant (Variation ID: 498281). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GAA protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
- -
A compound heterozygous variant in exon 4 of the GAA gene that results in the amino acid substitution of Aspargine for Serine at codon 265 was detected. The observed variant c.794G>A (p.Ser265Asn) has not been reported in the 1000 genomes and has MAF of 0.0024% in gnomAD databases. The in silico prediction of the variant is damaging by DANN. The reference codon is conserved across species. In summary, the variant meets our criteria to be classified as likely pathogenic. -
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at